Abstract:The easy tunable photophysical properties of Ru(II) polypyridyl complexes, together with their water solubility, photochemical stability and high biocompatibility make them suitable as agents for photodynamic therapy (PDT). The development of complexes containing new ligands is a step forward in the improvement and application of these compounds as photosensitizer and photocytotoxic agents. We report the synthesis of a set of Ru(II)-polypyridyl complexes with different electronic properties and delocalized π systems: one homoleptic complex [Ru II (dpbpy) 3 ](PF 6 ) 2 ( 1 ), and three heteroleptic complexes [Ru II (dpbpy) 2 (phen)](PF 6 ) 2 ( 2 ), [Ru II (dpbpy)(phen) 2 ](PF 6 ) 2 ( 3 ) and [Ru II (dpbpy) 2 (CN–Me)](PF 6 ) 2 ( 4 ). All of them contain 4,4′-diphenyl-2,2′-bipyridine ( dpbpy ) and 1,10-phenantroline ( phen ) or N-methyl-N′-2-pyridilimidazolium (CN–Me) ligands. The complexes have been characterized by spectroscopic, structural and electrochemical methods. UV–vis absorption in solution show the red shift for the metal to ligand charge transfer (MLCT) transitions after changing phen by dpbpy and carbene ligands. The photoluminescence emission spectra of 1 – 4 supported by theoretical calculations using time-dependent density-functional theory (TDDFT) suggest that the lowest energy excited state is mainly 3 MLCT. Complex 2 exhibits the highest phosphorescence emission with a quantum yield (Φ P ) in CH 2 Cl 2 of 44.1 %, followed by complex 1 (Φ P = 40.0 %), whereas complex 4 shows the lowest quantum efficiency (Φ P = 16.0 %), what suggest that the introduction of the CN–Me carbene ligand produces a significant quenching of the phosphorescence. Phosphorescence triplet state lifetimes between 0.96 and 1.74 μs were shown for 1 – 4 in degassed CH 2 Cl 2 . All complexes are proven to be efficient singlet oxygen photosensitizers. The trend in the redox potentials becomes more positive by increasing the number of phen ligands in the complexes, in full agreement with the HOMO's energy level and the blue shift of the MLCT transitions in the absorption spectra. Complexes internalization was analysed in tumorigenic mammary epithelial SKBR-3 cells, being complexes 1 and 2 the most well internalized. The effect of the photodynamic treatment using light-activated complexes 1 and 2 for 10 min demonstrated to increase cell death, being the homoleptic complex 1 an outstanding candidate as potential theranostic agent for bioimaging and PDT.

Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells

A Ru(II) complex-based COX-2 targeting type I photosensitizer evokes ferroptosis and apoptosis

Type I Photoreaction and Photoinduced Ferroptosis by a Ru(II) Complex to Overcome Tumor Hypoxia in Photodynamic Therapy

Platinated Porphyrin As A New Organelle and Nucleus Dual-Targeted Photosensitizer for Photodynamic Therapy

An AIE-based Monofunctional Pt(ii) Complex for Photodynamic Therapy Through Synergism of Necroptosis–ferroptosis

Substituent‐Modulated Excited Triplet States and Activities of Ruthenium Complexes for Dual Photodynamic/Sonodynamic Therapy to Cisplatin‐Resistant Non‐Small Cell Lung Cancer

Ru(II)-Photoactive Agents for Targeting ER Stress and Immunogenic Cell Death

Red-Light-Responsive Ru Complex Photosensitizer for Lysosome Localization Photodynamic Therapy

Lysosome Targeting Bis-terpyridine Ruthenium(II) Complexes: Photophysical Properties and in Vitro Photodynamic Therapy.

Converting an Almost Noncytotoxic Ru(II) Complex with Photolabile Ligands into a Highly Efficient PACT Agent

Developing photo-activable ruthenium (II) complexes for PDT: Synthesis, characterization, photophysical and biological studies

Sonoinduced Tumor Therapy and Metastasis Inhibition by a Ruthenium Complex with Dual Action: Superoxide Anion Sensitization and Ligand Fracture

A near-infrared light-activatable Ru(II)-coumarin photosensitizer active under hypoxic conditions

A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent

Uridine-Modified Ruthenium(II) Complex as Lysosomal LIMP-2 Targeting Photodynamic Therapy Photosensitizer for the Treatment of Triple-Negative Breast Cancer

Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance

Polyphosphoester-stabilized cubosomes encapsulating a Ru(II) complex for the photodynamic treatment of lung adenocarcinoma

A self-assembled Ru–Pt metallacage as a lysosome-targeting photosensitizer for 2-photon photodynamic therapy

Oxygen-dependent interactions between the ruthenium cage and the photoreleased inhibitor in NAMPT-targeted photoactivated chemotherapy

The cell-impermeable Ru(II) polypyridyl complex as a potent intracellular photosensitizer under visible light irradiation via ion-pairing with suitable lipophilic counter-anions

A two-photon excited O2-evolving nanocomposite for efficient photodynamic therapy against hypoxic tumor